NCT00089726View on ClinicalTrials.gov

A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC)

PHASE2CompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

March 31, 2003

Study Completion Date

January 31, 2006

Conditions
Lung CancerCarcinoma, Non-Small-Cell Lung
Interventions
BIOLOGICAL

CG8123

DRUG

Cyclophosphamide

Sponsors

Lead Sponsor

Cell Genesys
All Listed Sponsors
lead

Cell Genesys

INDUSTRY

NCT00089726 - A Cancer Vaccine (CG8123) Given With and Without Cyclophosphamide for Advanced Stage Non-Small Cell Lung Cancer (NSCLC) | Biotech Hunter | Biotech Hunter